2005•Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhiRequires access

Expression of MGMT in hepatocellular carcinoma and their clinical significance

Deng Xin-hui

Open publisher page 0 citations

Abstract

To study the expression and relationship between the expression and clinical pathological characterization of MGMT in Hepatocellular Carcinoma (HCC). Detect the expression of MGMT in cancer tissue of 37 HCC patients by SABC immunohistochemistry. The positive ratio of MGMT in center tissue of HCC was 18/37(48.7%), (2.24±1.77), which was lower obviously than that of paracarcinoma tissue 31/37(83.8%), (3.38±1.32) and normal liver tissue 15/17(88.2%), (3.94±1.66) (P 0.01); The expression of MGMT was associated with differentiation degree of HCC, but they were not associated with other clinical pathological characterization. [Conclusion] MGMT is important in restraining the occurrence and development of hepatocellular carcinoma. The expression of MGMT is maybe associated with the prognosis of HCC, but the advanced study will be needed.

About this research paper

What this paper is about

To study the expression and relationship between the expression and clinical pathological characterization of MGMT in Hepatocellular Carcinoma (HCC). Detect the expression of MGMT in cancer tissue of 37 HCC patients by SABC immunohistochemistry. The positive ratio of MGMT in center tissue of HCC was 18/37(48.7%), (2.24±1.77), which was lower obviously than that of paracarcinoma tissue 31/37(83.8%), (3.38±1.32) and normal liver tissue 15/17(88.2%), (3.94±1.66) (P 0.01); The expression of MGMT was associated with differentiation degree of HCC, but they were not associated with other clinical pathological characterization. [Conclusion] MGMT is important in restraining the occurrence and development of hepatocellular carcinoma. The expression of MGMT is maybe associated with the prognosis of HCC, but the advanced study will be needed.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To study the expression and relationship between the expression and clinical pathological characterization of MGMT in Hepatocellular Carcinoma (HCC). Detect the expression of MGMT in cancer tissue of 37 HCC patients by SABC immunohistochemistry. The positive ratio of MGMT in center tissue of HCC was 18/37(48.7%), (2.24±1.77), which was lower obviously than that of paracarcinoma tissue 31/37(83.8%), (3.38±1.32) and normal liver tissue 15/17(88.2%), (3.94±1.66) (P 0.01); The expression of MGMT was associated with differentiation degree of HCC, but they were not associated with other clinical pathological characterization. [Conclusion] MGMT is important in restraining the occurrence and development of hepatocellular carcinoma. The expression of MGMT is maybe associated with the prognosis of HCC, but the advanced study will be needed.

Key concepts: Hepatocellular carcinoma, Immunohistochemistry, Pathological, Medicine, Liver tissue, Clinical significance, Pathology, Liver cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of MGMT in hepatocellular carcinoma and their clinical significance — Research Paper | ScholarLens